RT Book, Section
A1 Lee, Jennifer H.
A1 Ruan, Daniel T.
A2 Morita, Shane Y.
A2 Balch, Charles M.
A2 Klimberg, V. Suzanne
A2 Pawlik, Timothy M.
A2 Posner, Mitchell C.
A2 Tanabe, Kenneth K.
SR Print(0)
ID 1145757529
T1 Follicular Thyroid Carcinoma
T2 Textbook of Complex General Surgical Oncology
YR 2018
FD 2018
PB McGraw-Hill Education
PP New York, NY
SN 9780071793315
LK hemonc.mhmedical.com/content.aspx?aid=1145757529
RD 2024/04/24
AB Historically,  practice  guidelines  and  various  medical  resources  have  combined  follicular  thyroid  cancer  (FTC)  with  papillary  thyroid  cancer  (PTC)  as  if  they  were  a  single  entity  of  “well-differentiated  thyroid  cancer.”  Although  they  are  derived  from  the  same  cell  of  origin,  they  are  each  driven  by  distinct  genetic  alterations  which  result  in  unique  clinical  characteristics.  There  are  important  differences  in  the  diagnostic  workup,  cancer  management,  and  prognosis  between  FTC  and  PTC.  Future  guidelines  and  studies  should  separate  them  as  distinct  clinical  entities.